The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
Authors
Keywords
Prostate cancer, ERG fusion, <em class=EmphasisTypeItalic >PTEN</em> deletion, SENP1, SUMO, Immunohistochemistry, Tissue microarray
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-22
DOI
10.1186/s12885-015-1555-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- βIII-Tubulin Overexpression Is an Independent Predictor of Prostate Cancer Progression Tightly Linked to ERG Fusion Status and PTEN Deletion
- (2014) Maria C. Tsourlakis et al. AMERICAN JOURNAL OF PATHOLOGY
- PTEN
- (2014) Carolyn A. Worby et al. Annual Review of Biochemistry
- The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
- (2014) Katharina Grupp et al. INTERNATIONAL JOURNAL OF CANCER
- Histone demethylase KDM5B is a key regulator of genome stability
- (2014) X. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer
- (2014) Katharina Grupp et al. PROSTATE
- Identification and Characterization of a New Chemotype of Noncovalent SENP Inhibitors
- (2013) Ikenna G. Madu et al. ACS Chemical Biology
- A Novel Reduced-Intensity Conditioning Regimen Induces a High Incidence of Sustained Donor-Derived Neutrophil and Platelet Engraftment after Double-Unit Cord Blood Transplantation
- (2013) Doris M. Ponce et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Interrogation ofERGgene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome
- (2013) Tarek A. Bismar et al. BJU INTERNATIONAL
- Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice
- (2013) O. M. Dovey et al. BLOOD
- Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies
- (2013) Dejan Knezevic et al. BMC GENOMICS
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort
- (2013) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers
- (2013) Laura Stumm et al. JOURNAL OF CLINICAL PATHOLOGY
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
- (2013) Katharina Grupp et al. MODERN PATHOLOGY
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers
- (2013) Katharina Grupp et al. Molecular Oncology
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
- (2013) Nicholas Erho et al. PLoS One
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- 2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation
- (2012) Yingyi Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- SENP1 deficiency promotes ER stress-induced apoptosis by increasing XBP1 SUMOylation
- (2012) Zhou Jiang et al. CELL CYCLE
- Histone deacetylase complexes as caretakers of genome stability
- (2012) Robert S. Lahue et al. Epigenetics
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- l-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome
- (2012) Chi-un Choe et al. HUMAN MOLECULAR GENETICS
- Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression inERG-fusion-positive cancers
- (2012) Julia Müller et al. INTERNATIONAL JOURNAL OF CANCER
- SUMO-specific protease 1 promotes prostate cancer progression and metastasis
- (2012) Q Wang et al. ONCOGENE
- Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression
- (2012) Weiwei Huang et al. PLoS One
- SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane
- (2012) Jian Huang et al. Nature Communications
- Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors
- (2011) Zhitao Qiao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors
- (2011) Ying Xu et al. CANCER LETTERS
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation
- (2011) Yuji Kubota et al. NATURE CELL BIOLOGY
- Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
- (2010) Anne Sofie Brems-Eskildsen et al. BMC CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2010) S. Gupta et al. CANCER RESEARCH
- Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer
- (2010) S. Minner et al. CLINICAL CANCER RESEARCH
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
- SUMO-Specific Protease 1 (SENP1) Reverses the Hormone-Augmented SUMOylation of Androgen Receptor and Modulates Gene Responses in Prostate Cancer Cells
- (2008) Sanna Kaikkonen et al. MOLECULAR ENDOCRINOLOGY
- A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
- (2008) Tohru Nakagawa et al. PLoS One
- A Novel Gene Signature for Molecular Diagnosis of Human Prostate Cancer by RT-qPCR
- (2008) Federica Rizzi et al. PLoS One
- Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays
- (2007) Sameer Jhavar et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started